|
Lactulose Clinical Trials
3 actively recruiting trials across 1 location
▲ +1 trial since June 2026
Also known as: Duphalac
Pipeline
Phase 4: 1Phase 1/2: 1
Top Sponsors
- University of Chicago1
- Post Graduate Institute of Medical Education and Research, Chandigarh1
- General Hospital of Shenyang Military Region1
Indications
- Liver Disease2
- Overt Hepatic Encephalopathy1
- Minimal Hepatic Encephalopathy1
- Decompensated Cirrhosis1
- Hepatic Encephalopathy1
Other2 trials
Chicago, Illinois1 trial
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
University of Chicago Medicine Comprehensive Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.